Imperative Care Announces Independent Randomized Clinical Trial for Treatment of M2 Occlusions in Stroke Patients
Imperative Care, Inc. today announced it will fund an investigator-initiated, multicenter, randomized, controlled clinical trial comparing aspiration thrombectomy with the Zoom Stroke System plus best medical treatment versus best medical treatment alone.